|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4184 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07D 403/04 | (2006.01) |
| (11) | Number of the document | 2722046 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14151089.1 |
| Date of filing the European patent application | 2008-10-10 | |
| (97) | Date of publication of the European application | 2014-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 979643 P | 2007-10-12 | US |
| (72) |
Kolaczkowski, Lawrence, US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (54) | 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |
| 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |